This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

20th - 22nd April 2021
★ 100% virtual conference ★Presented in Central European Time (CET)

Lawrence Liberti
Adjunct Assistant Professor at Temple University School of Pharmacy


Dr Liberti has worked in pharmaceutical regulatory affairs, communications, and clinical research and development (R&D) for the past four decades. He began his career at Wyeth Laboratories in product development, then as a regulatory writer in clinical R&D, and manager of safety surveillance in medical affairs.

He served as the editorial director for the North American operations of Adis International, after which he founded PIA Ltd, a company specializing in regulatory writing and consulting. He co-founded Astrolabe Analytica, and has served as the executive director of the Centre for Innovation in Regulatory Science (CIRS), forming part of Clarivate Analytics. Dr. Liberti received his doctorate in international regulatory policy through the WHO Collaborating Centre for Pharmaceutical Policy and Regulation. He holds the RAC and is a Fellow of the American Medical Writers Association.

Agenda Sessions

  • LATAM – Access to Innovation, Harmonization, Convergence, Reliance

  • How has COVID-19 Affected the LATAM Region and the Regulatory Landscape?